1. Home
  2. PROV vs PMN Comparison

PROV vs PMN Comparison

Compare PROV & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

N/A

Current Price

$17.13

Market Cap

106.0M

Sector

Finance

ML Signal

N/A

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

N/A

Current Price

$10.44

Market Cap

115.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PROV
PMN
Founded
1956
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Savings Institutions
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.0M
115.5M
IPO Year
2009
2022

Fundamental Metrics

Financial Performance
Metric
PROV
PMN
Price
$17.13
$10.44
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$16.25
$42.67
AVG Volume (30 Days)
6.2K
18.1K
Earning Date
04-28-2026
05-13-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
N/A
EPS
0.68
N/A
Revenue
N/A
N/A
Revenue This Year
$4.14
N/A
Revenue Next Year
$3.70
N/A
P/E Ratio
$25.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.95
$0.29
52 Week High
$17.42
$27.40

Technical Indicators

Market Signals
Indicator
PROV
PMN
Relative Strength Index (RSI) 56.05 47.99
Support Level $16.91 $9.20
Resistance Level $17.39 $11.37
Average True Range (ATR) 0.29 0.73
MACD 0.00 0.11
Stochastic Oscillator 74.46 55.38

Price Performance

Historical Comparison
PROV
PMN

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: